Clinical Trial Update: Therapeutic Utility of Xolair in Patients Undergoing Aspirin Desensitization [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the therapeutic utility of Xolair in patients undergoing aspirin desensitization has completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aspirin Sensitivity

Drugs mentioned

• Xolair (omalizumab)

Snippet

Sponsor: David Lang | Conditions: Aspirin Sensitivity | Phase 4 | Status: COMPLETED | Results posted: 2019-03-26